---
title: "SUNHERE: FOSUN PHARMA reduced its stake by 0.98%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244710061.md"
description: "SUNHERE announced that FOSUN PHARMA reduced its stake in the company by 0.98%. The reduction plan is expected to be completed by June 15, 2025, with an average reduction price of 12.54 yuan and a total of 2.2828 million shares reduced. After the reduction, FOSUN PHARMA holds 21.6453 million shares, accounting for 9.23% of the total share capital. This reduction does not violate any laws or regulations, and the company's operations are normal, with no change in control"
datetime: "2025-06-16T12:22:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244710061.md)
  - [en](https://longbridge.com/en/news/244710061.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244710061.md)
---

# SUNHERE: FOSUN PHARMA reduced its stake by 0.98%

SUNHERE announced that its shareholder Shanghai FOSUN PHARMA Industrial Development Co., Ltd., holding more than 5% of the shares, plans to reduce its holdings of the company's shares by no more than 6.978 million shares, or no more than 3% of the company's total share capital, through centralized bidding and block trading from March 18, 2025, to June 15, 2025. Recently, the company received a notification letter from FOSUN PHARMA regarding the completion of the share reduction plan, which was implemented on June 15, 2025. The average reduction price was 12.54 yuan, with a total reduction of 2.2828 million shares, accounting for 0.98%. After the reduction, FOSUN PHARMA holds 21.6453 million shares, representing 9.23% of the total share capital. This reduction plan did not violate relevant laws and regulations, the company's production and operation are normal, and there has been no change in control

### Related Stocks

- [600196.CN](https://longbridge.com/en/quote/600196.CN.md)
- [02196.HK](https://longbridge.com/en/quote/02196.HK.md)
- [300452.CN](https://longbridge.com/en/quote/300452.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [UPI changed how India pays; it can drive the future of borrowing](https://longbridge.com/en/news/286677065.md)
- [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md)